Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-10-24
2006-10-24
Spector, Lorraine (Department: 1647)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007210, C435S069100, C435S252300, C435S320100, C435S325000, C436S501000, C530S350000, C536S023100, C536S023500
Reexamination Certificate
active
07125676
ABSTRACT:
Isolated nucleic acids encoding human SCN1A polypeptides, recombinantly expressed and isolated human SCN1A polypeptides, heterologous expression systems for recombinant expression of human SCN1A polypeptides, assay methods employing the same, and methods and compositions for modulation of sodium channel function.
REFERENCES:
patent: 5670622 (1997-09-01), Shon et al.
patent: 5688830 (1997-11-01), Berger et al.
patent: 5776859 (1998-07-01), Nickel
patent: 5780242 (1998-07-01), Nickel
patent: 5858687 (1999-01-01), Manger et al.
patent: 5892018 (1999-04-01), Welsh et al.
patent: 6030810 (2000-02-01), Delgado et al.
patent: 6030974 (2000-02-01), Schwartz et al.
patent: 6060271 (2000-05-01), Walewski et al.
patent: 6110672 (2000-08-01), Mandel et al.
patent: 6110937 (2000-08-01), Loughhead et al.
patent: 6172085 (2001-01-01), Ohkawa et al.
patent: 6174690 (2001-01-01), Manger et al.
patent: 6184349 (2001-02-01), Herman et al.
patent: 2002/0076780 (2002-06-01), Turner, Jr. et al.
patent: 2004/0096885 (2004-05-01), Rouleau et al.
patent: WO 97/01577 (1997-01-01), None
patent: WO 97/42955 (1997-11-01), None
patent: WO 98/38302 (1998-09-01), None
patent: WO 98/43619 (1998-10-01), None
patent: WO 98/51290 (1998-11-01), None
patent: WO 99/47670 (1999-09-01), None
patent: WO 00/61188 (2000-10-01), None
patent: WO 00/61231 (2000-10-01), None
patent: WO 01/05831 (2001-01-01), None
patent: WO 01/38564 (2001-05-01), None
patent: WO 01/92304 (2001-12-01), None
patent: WO 02/50096 (2002-06-01), None
Wells, J.A. (1990). Additivity of mutational effects in proteins. Biochemistry. 29(37):8509-8517.
Ngo et al. (1994). Computational complexity, protein structure prediction, and the Levinthal paradox. In Merz and Le Grand (Eds.) The Protein Folding Problem and Tertiary Structure Prediction. Birkhauser:Boston, pp. 492-495.
Lossin et al.,Molecular Basis of an Inherited Epilepsy, Neuron34:877-884 (Jun. 13, 2002).
Abou-Khalil,Partial and generalized epilepsy with febrile seizures plus and a novel SCN1A mutation, Neurology57:2265-2272 (2001).
Abdul et al.,Inhibition by Anticonvulsants of Prostate-specific Antigen and Interleukin-6 Secretion by Human Prostate Cancer Cells, Anticancer Research21:2045-2048 (2001).
Alekov et al.,A sodium channel mutation causing epilepsy in man exhibits subtle defects in fast inactivation and activation in vitro, J. of Physiology529(3):533-539 (2000).
Alekov et al.,Enhanced inactivation and acceleration of activation of the sodium channel associated with epilepsy in man, European J. of Neuroscience13:2171-2176 (2001).
Baekelandt et al.,Gene therapeutic strategies for neurodegenerative diseases, Current Opinion in Molecular Therapeutics2(5):540-554 (2000).
Baulac et al.,A Second Locus for Familial Generalized Epilepsy with Febrile Seizures Plus Maps to Chromosome 2q21-q33, Am. J. Hum. Genet. 65:1078-1085 (1999).
Caron et al.,Adverse Effects of Class I Antiarrhythmic Drugs, Drug Safety1:8-36 (Jul. 1997).
Catterall,From Ionic Currents to Molecular Mechanisms: The Structure and Function of Voltage-Gated Sodium Channels, Neuron26:13-25 (Apr. 2000).
Catterall,Molecular Properties of Brain Sodium Channels: An Important Target for Anticonvulsant Drugs, Advances in Neurology79:441-456 (1999).
Claes et al.,De Novo Mutations in the Sodium-Channel Gene SCN1A Cause Severe Myoclonic Epilepsy of Infancy, Am. J. Hum. Genet. 68:1327-1332 (2001).
Coulter, Antiepileptic Drug Cellular Mechanisms of Action: Where Does Lamotrigine Fit In?J. of Child Neurology12(Supp 1):S2-S9 (Nov. 1997).
Diss et al.,Expression Profiles of Voltage-Gated Na+Channel α-Subunit Genes in Rat and Human Prostate Cancer Cell Lines, The Prostate48:165-178 (2001).
Duch et al.,Volatile anesthetics significantly suppress central and peripheral mammalian sodium channels, Toxicology Letters100-101:255-263 (1998).
Escayg et al.,Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2, Nature Genetics24:343-345 (Apr. 2000).
Escayg et al.,A Novel SCN1A Mutation Associated with Generalized Epilepsy with Febrile Seizures Plus-and Prevalence of Variants in Patients with Epilepsy, Am. J. Hum. Genet. 68:866-873 (2001).
Goldin,Diversity of Mammalian Voltage-Gated Sodium Channels, Annals New York Academy of Sciences40-50 (Date Unknown).
Hickenbottom et al.,Neuroprotective Therapy, Seminars in Neurology18(4):485-492 (1998).
Isom,Pathobiology of Visceral Pain: Molecular Mechanisms and Therapeutic Implications I. Cellular and molecular biology of sodium channel β-subunits: therapeutic implications for pain? Am. J. Physiol. Gastrointest. Liver Physiol. 278:G349-G353 (2000).
Lehmann-Horn et al.,Voltage-Gated Ion Channels and Hereditary Disease, Physiological Reviews79(4):1317-1372 (Oct. 1999).
Lu et al.,Differential expression of two sodium channel subtypes in human brain, FEBS303(1):53-58 (May 1992).
Malo et al.,Localization of a putative human brain sodium channel gene(SCN1A)to chromosome band 2q24, Cytogenet Cell Genet67:178-186 (1994).
Morgan et al.,β3: An additional auxiliary subunit of the voltage-sensitive sodium channel that modulates channel gating with distinct kinetics, PNAS97(5):2308-2313 (Feb. 29, 2000).
Noda et al.,Existence of distinct sodium channel messenger RNAs in rat brain, Nature320:188-192 (Mar. 13, 1996).
Noda et al.,Expression of functional sodium channels from cloned cDNA, Nature322:826-828 (Aug. 28, 1986).
Oh et al.,Novel splice variants of the voltage-sensitive sodium channel alpha subunit, NeuroReport9:1267-1272 (1998).
Peel et al.,Adeno-associated virus vectors: activity and applications in the CNS, J. of Neuroscience Methods98:95-104 (2000).
Sindrup et al.,Pharmacologic treatment of pain in polyneuropathy, Neurology55:915-920 (2000).
Wallace et al.,Neuronal Sodium-Channel α1-Subunit Mutations in Generalized Epilepsy with Febrile Seizures Plus, Am. J. Human Genetics68:859-865 (2001).
Waxman et al.,Voltage-gated sodium channels and the molecular pathogenesis of pain: A review, J. of Rehab. Res. and Develop. 37:5 1-13 (Sep./Oct. 2000).
Whitaker et al.,Distribution of Voltage-Gated Sodium Channel α-Subunit and β-Subunit mRNAs in Human Hippocampal Formation, Cortex, and Cerebellum J. of Compar. Neuro. 422:123-139 (2000).
George, Jr. Alfred L.
Lossin Christoph
Jenkins Wilson Taylor & Hunt, P.A.
Lockard Jon M.
Spector Lorraine
Vanderbilt University
LandOfFree
Expression system for human brain-specific voltage-gated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Expression system for human brain-specific voltage-gated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Expression system for human brain-specific voltage-gated... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3717853